Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 3Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Polycythemia Vera 1Leukemia, Myeloid, Acute 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 90Gemcitabine 81Paclitaxel 80Docetaxel 73Capecitabine 64Oxaliplatin 53Specimen Handling 51Fluorouracil 51Magnetic Resonance Spectroscopy 49Radiotherapy 48Bevacizumab 48Dexamethasone 45Cyclophosphamide 44Leucovorin 38Drug Therapy 38Irinotecan 36Doxorubicin 36Pemetrexed 35Injections 30Trastuzumab 28Vincristine 27Rituximab 27Radiosurgery 25Prednisone 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24Lenalidomide 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Interferons × Clear all
NCT04116502 2026-04-28

MITHRIDATE

University of Birmingham

Phase 3 Recruiting
586 enrolled
Myeloid

Polycythemia Vera

NCT06802718 2025-01-31

Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia

Peking University People's Hospital

Phase 3 Recruiting
96 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡